INTRODUCTION
The gut microbiome has been referred to as a "forgotten organ" [1] due to its capacity to influence host physiology.
The gut microbiome is incredibly diverse, with dominant phyla including Firmicutes, Bacteroidetes, Proteobacteria, Verrucomicrobia, Actinobacteria and Fusobacteria [2, 3] . Gut microbiome composition varies substantially among individuals and is thought to be a key determinant of susceptibility to several diseases [4] [5] [6] . The gut microbiome provides signals that promote immune cell maturation and ensure the normal development of immune func tion [7] , which is crucial for human life and profoundly inf luences human physiology and metabolism [8, 9] . Ulcerative colitis (UC) is a form of inflammatory bow el disease that can lead to bloody diarrhoea, passage of pus and/or mucus, and abdominal cramping during bowel movements [10, 11] . Immune dysfunction plays a key role in driving inflammatory responses during UC devel opment and progression. UC is commonly treated with therapeutics such as the antiinflammatory drugs mesa lazine and sulphasalazine, with steroid enemas [12] or with surgical intervention. The aetiology and pathogenesis of UC have not been fully elucidated but are thought to result from detrimental interactions among intestinal microbiota, the gut epithelium, and the host immune system in genetically susceptible individuals [13, 14] . Several studies have recently reported decreased gut microbial diversity in patients with active UC [15, 16] . Microbial dys biosis is an important pathological factor of UC that affects host mucosal immunity [1719] . Pathogenic bacteria and opportunistic pathogens interact with the intestinal mucosa directly or indirectly via secreted toxins, which may lead to an inappropriate intestinal mucosal immune response.
Studies have demonstrated that moxibustion, a traditional Chinese therapy that treats and prevents diseases using moxa (floss of Artemisia argyi), is a safe and effective treatment for UC [2023] . Moxibustion exerts its therapeutic effects by regulating immune function [24, 25] , apoptosis [26, 27] , and protein expression at acupuncture points and in colon tissues [28, 29] . UC is asso ciated with changes in the gut microbiome, and moxi bustion modulates the imbalance of intestinal flora [30] . Nevertheless, the gut microbiome is a complex com munity with only a small proportion of culturable orga nisms, and the effect of moxibustion on the gut micro biome remains unknown. Recently developed culture independent highthroughput sequencing methods allow gut microbiome profiling and assessments of microbial gene abundance and community structure to be performed more easily [31] . Here, we used 16S rRNA gene sequencing to assess the gut microbial composition and community structure in faecal samples of UC rats treated with moxibustion or mesalazine gavage. Our aims were to determine the impact of moxibustion on intestinal microbial community structure, the role of the intestinal microbiota in UC patho genesis, and the molecular mechanism underlying the effect of moxibustion in UC treatment.
MATERIALS AND METHODS

Rats and groups
Seventy specific pathogenfree male Sprague Dawley rats (body weight 180220 g) were provided by the Department of Laboratory Animal Science of Fudan University (Shanghai Slack Laboratory Animal Co., LTD. license: SCXK (Shanghai) 20120002 and SYXK (Shanghai) 20090082). All rats were raised under standard conditions: 25 ± 1 ℃, 50%70% humidity, and 12 h light/dark cycle. Rats were allowed to acclimatize for one week before the start of the trial. Rats (n = 70) were divided into seven groups: healthy controls (HC), healthy controls with seven days of moxibustion (HC7), healthy controls with fourteen days of moxibustion (HC14), UC model group (UC), UC model with seven days of moxibustion (UC7), UC model with fourteen days of moxibustion (UC14), and UC model with mesalazine gavage (UCW). UC was induced with 4% dextran sulphate sodium (DSS; molecular weight: 3600050000 Da; Art.No.9011181; MP Biomedicals) supplied in drinking water. Animal breeding, care and all experiments were performed according to procedures approved by the University Animal Care and Use Com mittee of Shanghai University of Traditional Chinese Medicine (IACUC protocol number: SYXK (shanghai) 20090082) to relieve pain and avoid injury. All protocols were performed in strict accordance with the Guidance Suggestions for the Care and Use of Laboratory Animals, as formulated by the Ministry of Science and Technology of the People's Republic of China [32] . We tried all efforts to minimize animal suffering.
DSS-induced-colitis
UC was induced with 4% DSS in drinking water for seven consecutive days as described previously [33] . After seven days, two rats were randomly selected to confirm successful establishment of the animal model. Rats were provided 1% DSS in the drinking water for seven consecutive days in the UC, UC7 and UCW groups and fourteen consecutive days in the UC14 group.
Treatment
For the HC7 (n = 10) and UC7 (n = 10) groups, moxa cones (0.5 cm in diameter and 0.6 cm high) (Nanyang Hanyi Moxa Co., Ltd. China) were placed on the herb cake, and the herb cake was placed on Tianshu (ST25, bilateral) with moxibustion for 10 min once a day for seven days, the herb cakes were prepared with Chinese medicine powder and yellow wine into size of 1.0 cm in diameter and 0.5 cm in thickness, and the skin tempe rature of acupuncture points was 43 ± 1 ℃. ST25 is 5 mm lateral to anterior midline at the navel level [34] . The HC14 (n = 10) and UC14 (n = 10) groups received the same treatment as the HC7 and UC7 groups, respectively, but for fourteen days. The UCW group (n = 10) received mesalazine entericcoated tablets (Heilongjiang Tianhong Pharmaceutical Co., Ltd; Lot number: H20103359) by gavage administration twice daily for seven consecutive days with a dose calculated from that specified for an adult of 70 kg and a weight ratio of 1:0.018 for rats (200 g). The HC (n = 10) and UC (n = 10) groups did not receive any treatment but received the same fixation (to fix the hands and feet on the fixed mount).
Sample collection and processing
Following treatment, rats were anaesthetized via intraperitoneal injection with 2% pentobarbital sodium for tissue collection. Blood samples were collected by abdominal aortic, after one hour standing, the samples were centrifuged at 3000 rpm for ten minutes at 4 ℃ to separate the plasma. The obtained plasma was stored at -80 ℃. Colon samples were rapidly removed and separated from the large intestine (6 cm distal to the anus). Then, 5 g of faecal matter was collected in cryogenic vials and stored at 80 ℃. Colon samples were flushed with physiological saline to remove the surrounding connective tissue and fat. Colonic mucosal injury was observed with the naked eye. Then, the colon was divided into two segments: one segment was fixed in 10% paraformaldehyde for haematoxylin and eosin (HE) staining for histological observation and the histological grade was scored with the bland method [30] ( Table 1) , whereas the other segment was stored at -80 ℃.
Haematoxylin and eosin staining
Colon samples fixed with 10% paraformaldehyde were dehydrated and immersed in wax using an automatic tissue dehydrating machine, embedded in paraffin and sectioned at 4 μm thickness with a microtome. Slices were incubated with xylene Ⅰ and Ⅱ for 20 min each and rehydrated in absolute alcohol, 95% alcohol, 85% alcohol and 75% alcohol (3 min each time). Slices were stained with haematoxylin for 1 min, followed by 1% hydrochloric acidalcohol for 30 s, and counterstained tion of Unobserved States (PICRUSt 1.0.0) [37] was used to predict metagenome function from the 16S rRNA data. Statistical Analysis of Metagenomic Profiles (STAMP) [38] was used to analyse the predicted metagenome and to identify pathways associated with UC. The Benjamini Hochberg procedure was used to control the false discov ery rate due to multiple testing.
PCR analysis
Total RNA was isolated using TRIzol ® LS (Invitrogen Corp.) according to the manufacturer's instructions. The integrity of the RNA samples was assessed via agarose gel (10 g/L) electrophoresis, and RNA concentrations were determined using a NanoDrop ND2000 Spectro photometer (Thermo Electron Corporation). Two micro grams of total RNA was used for RTPCR in a 20 μL reverse transcription reaction system. Two micrograms of RNA, up to 8 μL of DEPC, 0.5 μL (50 U/μL) of RNase inhibitor and 2 μL of oligomer (dT)15 and primer were mixed and placed in a 65 ℃ water for 5 min. Then, the mixture was placed at room temperature for 10 min. After a 5 s centrifugation, the following reagents were added to the reactions: 0.5 μL (50 U/μL) of RNase inhibitor, 4 μL of 5 × RT buffer solution, 2 μL of dNTPs (10 mmol/L for each), 2 μL of DTT, and 1 μL of AMV reverse transcriptase (200 U/μL). The solution was mixed and placed in water at 40 ℃ for 1 h, heated to 90 ℃ in water for 5 min, and centrifuged for 5 s.
The primers used were designed with Primer Express Software v2.0 (Applied Biosystems, United States) and synthesized at the Beijing Genomics Institute. Gene sequences of the primers are presented in Table 2 .
Each 16 μL PCR included: 8 μL of 2 × SYBR Green PCR mix, 1 μL of each sense and antisense primer, 1 μL of reverse transcription product (cDNA), and 5 μL of H2O. RTPCR was performed using a ViiA 7 Real Time PCR System (Applied Biosystems, United States). The reaction conditions were set at 95 ℃ for 2 min, 94 ℃ for 10 s, 60 ℃ for 10 s, and 72 ℃ for 40 s for 40 cycles.
ELISA analysis
The levels of interleukin2, 10, 12, 17, 23, interferonγ (IFNγ), lipopolysaccharide (LPS), immunoglobulin A (IgA), transforming growth factorβ (TGFβ), tumour necrosis factor-α (TNFα), TNF receptor 1 (TNFR1) and TNFR2 in all serum samples were tested by sandwich ELISA. According to manufacturer's instructions, IL2, IL10, IL12, 17, IL23, IFNγ, LPS, IgA, TGFβ, TNFα, TNFR1 and TNFR2 were measured using corresponding ELISA kits (Biotech well, Shanghai, China). The detection limits were: 17 pg/mL for IL2, IL12, IL23, and TNFα, 16 pg/mL for IL10, 15 pg/mL for IL17, and TGFβ, 12 pg/mL for IFNγ, 8 pg/mL for LPS, 8ng/mL for IgA, 6 pg/ mL for TNFR1, and 5 pg/mL for TNFR2.
Statistical analysis
Differential abundance testing between groups was performed using the KruskalWallis test in R 3.2.3 (http:// cran.rproject.org). Alpha diversity was measured with with eosin for 5 min. Sample histology was observed by electron microscope.
Bacterial genomic DNA extraction
Genomic DNA was extracted from faecal samples using the QIAamp DNA Mini Kit (QIAGEN, Germany). Briefly, 20 μL of proteinase K solution (20 mg/mL) and 100 mg of zirconium beads (0.1 mm) were added to the pellet. The mixture was agitated three times with a MiniBeadbeater (FastPrep, Thermo Electron Corporation, United States); buffer AL was added to the mixture, which was then incubated for 10 min at 70 ℃. Next, 200 μL of ethanol (96%) was added. This mixture was then loaded onto a QIAamp Mini spin column and centrifuged at 8000 g for 1 min. The column material was washed with the first washing buffer (buffer AW1, 500 μL) followed by the second washing buffer (buffer AW2, 500 μL) provided with the kit. Finally, DNA was eluted with 100 μL of buffer AE. DNA integrity was assessed by electrophoresis on a 1% agarose gel containing 0.5 mg/mL ethidium bromide. DNA concentrations were determined using a NanoDrop ND2000 spectrophotometer (Thermo Elec tron Corporation).
Illumina sequencing and data processing
The 16S rRNA gene hypervariable V3V4 region was amplified by PCR using the barcodetag universal bacterial modified primers. The prototype primers were 341F (5'ACTCCTACGGGAGGCAGCAG3') and 806R (5'GGACTACVVGGGTATCTAATC3'). Amplicon sequen cing was performed using Illumina MiSeq (PE300). Raw reads were demultiplexed and filtered according to read length and quality. Chimeric reads were removed, and OTU selection was performed as previously described [35] . The filtered reads were dereplicated to unique sequences and sorted by abundance before being subjected to OTU clustering at 97% similarity. Taxonomy was assigned to the representative sequence of each OTU using the Ribosomal Database Project classifier [36] . 
Prediction of metagenome functional content
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Simpson and Shannon diversity indices. Beta diversity was determined using unweighted unifrac distance and was summarized by PCoA. A principal components ana lysis (PCA) plot of Kyoto Encyclopaedia of Genes and Genomes (KEGG) modules with significant differences in mean proportion differences was created using STAMP [39] (v2.1.3). Body weight gain, RTPCR and ELISA analysis data are presented as the mean ± SD. Histopathological score data are expressed as M (Q25Q75). ANOVA and Least Significant Difference multiple comparison tests were performed using IBM SPSS statistics 21.0 (IBM Co., Armonk, NY, United States). P < 0.05 was considered significant.
RESULTS
Body weight gains in different groups
Two rats in the UCW group died after gavage during the experiment. The body weight gain in the UC group was lower than that in the HC group (P < 0.01). After treatment, the body weight gains in the UC7, UC14, HC7, HC14 (P < 0.01) and UCW (P < 0.05) groups were higher than that in the UC group ( Figure 1 ).
Changes in the colon histopathology
Rat colons were observed by light microscopy ( Figure  2 ). The HC, HC7, and HC14 groups had similar histopathologies, with intact colonic mucosal epithelia, regularly arranged glands, and evenly distributed me senchyme. No congestion, oedema, ulcers or other pathological abnormalities were noted. By contrast, UC rats exhibited colonic mucosa damage, with a reduced number of glands and substantial inflammatory cell infiltration in the mucosa and submucosa. These abnor malities could be alleviated by moxibustion treatment, which restored the colonic mucosa to the level of healthy rats, and decreased submucosal inflammatory cell infil tration and congestion in the UC7 and UC14 groups. However, in the UCW group, mucosal and submucosal glands were disorganized, with abundant inflammatory cell infiltration. The histopathological scores for the colon tissues in the different groups are presented in Figure  3 . The histopathological scores in the UC group were significantly higher than those in the HC group (P < 0.01). After treatment, the scores were decreased in the UC7, UC14, UCW, HC7 and HC14 groups compared with those in the UC group (P < 0.01).
Core bacteria
Approximately 3.9 million highquality (> 220 bp) se quence reads were obtained using the MiSeq system (Illumina, San Diego, CA, United States), which led to the identification of 1545 operational taxonomic units (OTUs), with an average read length of 451.58 bp. Overall, the healthy controls with fourteen days of moxibustion. The body weight gain in the UC group was decreased compared with the HC group (P < 0.01). After treatment, the body weight gains in the UC-7, UC-14, HC-7, HC-14 (P < 0.01) and UC-W (P < 0.05) groups were increased compared with the UC group. b P < 0.01 vs the HC group; c P < 0.05, d P < 0.01 vs the UC group.
relative abundance levels of 18 dominant phyla were identified in the entire model system. Among these phyla, five (Firmicutes, Bacteroidetes, Proteobacteria, Candidatus Saccharibacteria, and Actinobacteria) were present at ≥ 1% and were the dominant phyla in all groups, but relative abundance varied by treatment. A total of 186 families were detected, and 100 families were commonly present, of which Lachnospiraceae, Ruminococcaceae, Porphyromonadaceae, Lactobacil laceae, Sphingomonadaceae, Veillonellaceae and Corio bacteriaceae were the dominant families detected. A total of 325 OTUs were identified at the genus level, of which 10 core OTUs were present in all groups. The highest average number of OTUs identified at the genus level (134) was detected in the UC14 rats, whereas the lowest (78) was found in HC rats. As shown in Figure 4 , the UC group had the most unique genera, even after treatment with either moxibustion or mesalazine gavage.
Community abundance variation between healthy controls and UC model rats
There were significant differences in the microbiome between healthy controls and UC rats. Although Firmi cutes was the predominant phylum in all samples, UC rats had increased relative abundance levels of Proteobacteria, Candidatus and Saccharibacteria and decreased relative abundance levels of Firmicutes and Actinobacteria compared with HC rats. At the family level, UC rats had decreased Lactobacillaceae and Ruminococcaceae and increased Sphingomonadaceae, Pseudomonadaceae and Porphyromonadaceae ( Figure  5B ). In addition, Lactobacillus, Clostridium ⅩⅣa and Ruminococcus were increased and Saccharibacteria and Sphingomonas were decreased in HC compared with UC rats ( Figure 5C ). UC rats had lower alpha diversity than HC rats, and the Shannon Diversity Index was reduced ( Figure 5D ), consistent with previous reports [15, 40] .
Community abundance variations between healthy controls with or without moxibustion treatment
In HC7 and HC14 groups, Firmicutes were decreased and Bacteroidetes and Proteobacteria were increased compared with the HC group ( Figure 5A) . At the family level, Porphyromonadaceae was increased and Ruminococcaceae and Veillonellaceae were de creased in moxibustiontreated groups ( Figure 5B ). Compared with the HC7 group, the HC14 group had increased abundance levels of Lachnospiraceae and Ruminococcaceae and a decreased abundance of Lactobacillaceae. At the genus level, Lactobacillus and Desulfovibrio were significantly increased, and Ruminococcus and Barnesiella were significantly de creased in both HC7 and HC14 groups relative to HCs. In particular, significant differences between HC7 and HC14 were noted regarding the abundance levels of Lactobacillus, Saccharibacteria, and Blautia. HC7 exhibited increased abundance levels of Lactobacillus and Blautia and a reduced abundance of Saccharibacteria compared with those in the HC14 group. Lactobacillus and Pseudomonas were significantly enriched in HC7 (but not HC14) compared with the HC group. Interestingly, Saccharibacteria was decreased in HC7 but increased in HC14 compared with HCs ( Figure 5C ). It is not clear why the alpha diversity was decreased in HC7 but increased in HC14 compared with HCs ( Figure 5D ).
Community abundance variations between UC groups with or without moxibustion treatment
Moxibustion treatment (but not mesalazine gavage) for seven days or fourteen days was associated with an increase in Firmicutes compared with the UC group, whereas Proteobacteria and Candidatus and Saccharibacteria were decreased to varying degrees in both the moxibustion and mesalazinetreated groups compared with the UC group. Bacteroidetes was reduced in UC14 but substantially increased in the UCW group compared with the UC group ( Figure 5A) . At the family level, UC7 was similar to UCW but significantly different from UC14. UC14 exhibited increased Sphingomonadaceae and decreased Porphyromonadaceae compared with UC7 and UCW. Coriobacteriaceae, Pseudomonadaceae and Bifidobacteriaceae were significantly reduced in UC7, UC14 and UCW groups compared with the UC group ( Figure 5B ). UC14 had relatively low levels of Lactobacillus but relatively high levels of Clostridium XIVa and Sphingomonas with a dominant position in all groups. In the UCW group, Saccharibacteria was decreased and Barnesiella, Prevotella, and Alloprevotella were increased significantly compared with all of the other groups ( Figure 5C ).
Biodiversity and microbial richness
Alpha diversity was estimated through rarefaction analysis and the Shannon and Chao1 indexes. The lowest OTU richness was observed in the HC groups. Multiple rarefaction curves analysis indicated variation among samples and exhibited sufficient data coverage for diversity in the samples. The Shannon Wiener index showed the lowest value of evenness in HC rats. Surprisingly, HC7 also showed a lower value. Interest ingly, after seven days of treatment with moxibustion, the genus level diversity was comparable to that of HCs but notably different from the UC14 and UCW groups. UC7 and UCW had the highest median alpha diversity, which was restored to the normal level of HC and HC14 ( Figure 5D ). This finding suggests that both moxibustion treatment and mesalazine gavage increased colonic microbial diversity. In terms of betadiversity, UC samples clustered separately from HC samples in a principal coordinates analysis (PCoA), indicating that disease state was the primary factor influencing community differences ( Figure 6 ). UC 7 was more similar to UCW on the first axis, whereas HC7 and HC14 were more similar to HC and UC14. Using nonmetric multidimensional scaling (nMDS) instead of PCoA produced similar results ( Figure  7 ). 
Genus level differences among treatment groups
To establish which taxa were contributing most to the apparent differences in diversity between groups, genus level abundance was assessed. Saccharibacteria, Ruminococcus, Sphingomonas, Pseudomonas, Clostridium Ⅳ, Prevotella and Alloprevotella were the most affected genera (Figure 8 ). These opportunistic pathogens can cause infection and may be important contributing factors in UC pathogenesis. Indeed, both Bacteroidetes [41] and Clostridium Ⅳ [42] are associated with UC. In our study, we found that UC rats had a higher density of Bacteroidetes and reduced Clostridium Ⅳ compared with the control.
Predictive functional profiling of microbial communities
Community function was inferred from 16S composi tional data using PICRUSt. In the KEGG pathway analysis, ascorbate and aldarate metabolism were sig nificantly increased in both UC and HC rats treated with moxibustion for fourteen days (Supplement Table 1 ), which suggests that longterm moxibustion treatment could increase ascorbate and aldarate metabolism. Furthermore, compared with the HC group, the HC7 and HC14 groups had significant increases in genes belonging to the amino acid metabolism pathway. Com pared with the UC group, these genes were increased in the UC7 and UC14 groups, but no significant dif ferences were noted. However, the roles of these meta bolic pathways in UC are unclear.
Levels of IL-6, IL-10, IL-12, IL-17, IL-23, TNF-α, TNFR1 and TNFR2 mRNA in colon mucosa
IL6, IL17, IL23, TNFα, TNFR1 and TNFR2 (P < 0.01) and IL12 mRNA (P < 0.05) exhibited significant Qi Q et al . Moxibustion modulates gut microbiota in colitis The relative abundance levels of Proteobacteria, Candidatus, and Saccharibacteria were increased, whereas Firmicutes and Actinobacteria were decreased in the UC group compared with the HC group. These changes in microbiota profiles could be reversed by moxibustion treatment for seven days or fourteen days; B: UC rats had decreased Lactobacillaceae and Ruminococcaceae and increased Sphingomonadaceae, Pseudomonadaceae, and Porphyromonadaceae compared with the HC group. After treatment, Pseudomonadaceae was reduced in the UC-7, UC-14 and UC-W groups compared with the UC group; C: Lactobacillus, Clostridium XlVa, and Ruminococcus were increased and Saccharibacteria and Sphingomonas were decreased in HC rats compared with UC rats; D: UC rats had decreased alpha diversity compared with HC rats. After treatment, alpha diversity was increased in the UC-7 and UC-W groups. Healthy controls with fourteen days of moxibustion. UC rats had a higher density of Bacteroidetes and a lower Clostridium Ⅳ density compared with HC rats.
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Relative expression The relative expression levels of IL-12 (P < 0.05), IL-6, IL-17, IL-23, TNF-α, TNFR1 and TNFR2 (P < 0.01) in the UC group were increased compared with the HC group. IL-10 (P < 0.01) expression levels in the UC group were decreased compared with the HC group. IL-17, IL-23, TNF-α, TNFR2 (P < 0.01), IL-6, IL-12, and TNFR1 (P < 0.05) expression levels were decreased in the UC-7 group compared with the UC group. TNF-α, TNFR1 (P < 0.05), IL-12, IL-6, IL-17, and IL-23 (P < 0.01) expression levels in the UC-14 group were decreased compared with UC rats. IL-10 was higher in the UC-7 group (P < 0.01), the UC-14 group (P < 0.01), and the UC-W group (P < 0.05) compared to the UC group. IL-6, IL-17, IL-23, TNF-α, TNFR1, and TNFR2 (P < 0.01) expression levels were decreased in the UC-W group compared with the UC group. a P < 0.05, b P < 0.01 vs the HC group; c P < 0.05, d P < 0.01 vs the UC group.
increases and IL10 mRNA (P < 0.01) exhibited a sig nificant decrease in the UC rats compared with their expression levels in HC rats ( Figure 9 ). We found signifi cantly lower levels of IL17, IL23, TNFα, TNFR2 (P < 0.01), IL6, IL12, and TNFR1 mRNA (P < 0.05) in the UC7 group compared to the UC group. The relative expression levels of IL6, IL12, IL17, IL23 (P < 0.01), TNFα and TNFR1 mRNA (P < 0.05) were also lower in the UC14 group than in the UC group, and IL10 mRNA was both higher in the UC7 group (P < 0.01), the UC14 group (P < 0.01) and the UCW group (P < 0.05) than in the UC group. However, no significant differences in the relative expression levels of TNFR2 mRNA were noted between the UC14 and UC groups (P > 0.05). Significant decreases in IL6, IL17, IL23, TNFα, TNFR1, and TNFR2 mRNA (P < 0.01) were also noted in the UCW group compared with the UC group.
The levels of IL-2, IL-10, IL-12, IL-17, IL-23, IFN-γ, LPS, IgA, TGF-β, TNF-α, TNFR1 and TNFR2 in serum
As shown in Figure 10 , we noted lower levels of IL2, IL10 (P < 0.01) and TGFβ (P < 0.05) and higher levels of IL12 (P < 0.05), IL17, IL23, IFNγ, LPS, IgA, TNFα, TNFR1 and TNFR2 (P < 0.01) in the UC group compared with HC group. Interestingly, we also noted significantly higher levels of IL2 (P < 0.01), IL10 (UC7, P < 0.05; UCW and HC7, P < 0.01) and TGFβ (UC7 and UCW, P < 0.05; HC7, P > 0.05) in treatment groups than the UC group. Similarly, the levels of IL17 (UC7 and HC7, P < 0.05; UCW, P < 0.01), IL23, IFNγ, LPS, IgA, TNFR1, TNFR2 (P < 0.01), TNFα (P < 0.05) in serum were lower in the UC7 and UCW groups. However, there were no significant differences in the level of IL12 between the UC group and the UC7 group and between the UC group and the UCW group (P > 0.05). The results were not completely consistent with the PCR. ELISA is a quantitative method to detect proteins, and PCR is the detection of the target gene from the transcript level. Due to posttranscriptional and posttranslation regulation, gene expression and protein expression do not necessarily correlate.
DISCUSSION
In the last decade, several studies have revealed a strong association between gut microbiome dysbiosis and UC [17, 4345] . According to the traditional Chinese medicine theory, the Tianshu (ST25) acupoint is the Mu point of large intestine and can regulate gastrointestinal functions, and is usually used to treat abdominal pain and diarrhoea [46] . Moxibustion is an effective and safe treatment for UC, but the underlying mechanism remains unknown. Moxibustion treatment regulates intestinal flora and inhibits TNFα and IL12 expression in the colon tissues of UC rats, which can regulate the colonic immune response [30] . However, no study has investigated the effects of moxibustion on the intestinal flora using whole microbiome analysis. Therefore, we employed a 16S rRNA amplicon sequencing approach to determine the effects of moxibustion treatment on the microbiome in a UC rat model.
We found that moxibustion treatment increased Firmicutes abundance and decreased the abundance levels of Bacteroidetes and Proteobacteria. In terms of alpha diversity, HC14 was more similar to HC than HC7, which was confirmed by PCoA. In terms of alpha diversity, UC14 was also more similar to UC than UC7. This finding suggests that shortterm (seven days) but not longer term (fourteen days) moxibustion treatment may significantly affect the gut microbiome. Overall, the relative abundance levels of beneficial bacteria were decreased, and the growth of several opportunistic pathogenic species was increased in the UC rats.
We found that gut microbiome diversity was signifi cantly reduced in UC rats compared with healthy con trols, consistent with previous reports. The abundance levels of Firmicutes, Bacteroidetes and Proteobacteria Candidatus varied between treatment groups. In particular, Firmicutes was less abundant in UC rats. At the family level, this effect translated to reductions in host beneficial taxa, including Ruminococcaceae and Lactobacillaceae, which are closely associated with UC [47] . At the genus level, Lactobacillus, Bifidobacterium and Ruminococcus were decreased in UC rats, consistent with the literature [15, 46] . Several studies have reported that Lactobacillus and Bifidobacterium played key roles in treating UC patients or rats by inhibiting Tolllike receptor 4 expression to reduce TNFα expression [47] and enhancing antiinflammatory cytokine IL10 pro duction [48] . UC pathogenesis may be associated with the decreased levels of Lactobacillus and Bifidobacterium, which consequently led to increases in inflammatory cytokines and decreases in antiinflammatory cyto kines. Lactobacillus and Bifidobacterium can down regulate inflammatory cytokines [49] and stimulate anti inflammatory cytokines, such as IL10 [50] , which may protect the host from mucosal inflammation. Interestingly, we found that the expression levels of inflammatory cytokines, such as IL6, IL12, IL17, IL23, IFNγ, TNFα, TNFR1 and TNFR2, were increased and that anti inflammatory cytokine IL10 and TGFβ expression was decreased in UC rats compared with HC rats. These results indicate that gut microbial variation may affect mucosal immunity through upregulating inflammatory cytokines and downregulating antiinflammatory cyto kines. However, the specific relationship between the gut microbiome and mucosal immunity needs further investigation. After moxibustion treatment, the levels of these inflammatory cytokines were significantly decreased, and antiinflammatory cytokines were increased. These results demonstrated that moxibustion treatment may repair intestinal mucosal by downregulating inflammatory cytokines and upregulating antiinflammatory cytokines. In an animal model of colitis, butyrateproducing bacteria alleviated intestinal inflammation and necrosis in colitis rats [50] . UC patients have fewer butyrateproducing bacteria, such as Clostridium leptum and Clostridium coccoides [51, 52] , which is supported by our findings. Healthy controls with seven days of moxibustion. IL-2, IL-10 (P < 0.01) and TGF-β (P < 0.05) were lower and IL-12 (P < 0.05), IL-17, IL-23, IFN-γ, LPS, IgA, TNF-α, TNFR1 and TNFR2 (P < 0.01) were higher in the UC group compared with the HC group. The levels of IL-2 (P < 0.01), IL-10 (UC-7, P < 0.05, UC-W and HC-7, P < 0.01) and TGF-β (UC-7 and UC-W, P < 0.05, HC-7, P > 0.05) were higher in the treatment groups than the UC group. The levels of IL-17 (UC-7 and HC-7, P < 0.05, UC-W, P < 0.01), IL-23, IFN-γ, LPS, IgA, TNFR1, TNFR2 (P < 0.01), and TNF-α (P < 0.05) in serum were lower in the UC-7 and UC-W groups. However, there were no significant differences in the level of IL-12 between the UC group and the UC-7 group and between the UC group and the UC-W group (P > 0.05). a P < 0.05, b P < 0.01 vs the HC group. c P < 0.05, d P < 0.01 vs the UC group.
In UC rats, both moxibustion and mesalazine gavage for seven days led to increases in microbial diversity. Several studies have reported that mesalazine can improve the clinical symptoms and colon mucosal condi tion in UC patients [53, 54] . These results demonstrate that moxibustion could potentially be used as an alternative treatment to mesalazine. It is not clear why the alpha diversity was decreased in UC rats treated with moxi bustion for fourteen days. It is possible that moxibustion is not suitable for longterm treatment of UC, and deter mining whether moxibustion has side effects requires further study. PCoA analysis showed that UC rats had distinct microbiome profiles compared with HC rats, and an increased similarity in PCoA axis scores was noted between the HC and UC14 groups. These results indicate that moxibustion could possibly decrease distinct bacteria, such as opportunistic pathogens.
Highthroughput sequencing offers a new tool for studying the effect of moxibustion on the gut microbiome and its mechanism of action. Here, we report reduced diversity, gut microbial dysbiosis, increased inflammatory cytokines and decreased antiinflammatory cytokines in DSSinduced colitis rats and show that these effects could be alleviated by moxibustion treatment. Our findings suggest that moxibustion exerts its therapeutic effect by modulating the microbiome and intestinal mucosal immunity. Bacterial functions possibly associated with moxibustion treatment include ascorbate and aldarate metabolism and amino acid metabolism.
ARTICLE HIGHLIGHTS
Research background
The aetiology and pathogenesis of ulcerative colitis (UC) are not clear. In recent years, there has been growing evidence that the gut microbiota has a key role in the development of UC. Our previous study has shown that there are an imbalanced states of the beneficial bacteria Bifidobacterium, Lactobacillus, and harmful bacteria E. coli and Fusobacterium in the intestine of UC rats, and moxibustion can regulate the balance of beneficial bacteria and harmful bacteria in the intestine of UC rats.
Research motivation
Many studies have confirmed the efficacy of moxibustion in UC, however, the role of gut microbiota in the pathogenesis of UC and the role of moxibustion in the regulation of the UC gut microbiota remain unclear.
Research objectives
The aim of this work is to investigate the effect and mechanism of moxibustion on gut microbiota in UC rats.
Research methods
UC was induced with 4% DSS in drinking water for seven consecutive days. Moxibustion was applied to the Tianshu (ST25, bilateral). Haematoxylin and eosin staining was assessed to evaluate the changes in the colon histopathology. Gut microbiome profiling was conducted by 16S rRNA amplicon sequencing, and PCR and ELISA determined the expression of inflammatory cytokines.
Research results
Compared with the healthy controls (HC) group, the UC group had increased histopathological scores. After treatment, the scores were decreased in the UC-7, UC-14, UC-W, HC-7 and HC-14 groups compared with those in the UC group. The relative abundance of some of the bacteria in the UC group was changed at both the phylum, family and genus level. In addition, UC rats had reduced alpha diversity, which all could be alleviated by moxibustion therapy. Moxibustion can significantly reduce the levels of pro-inflammatory cytokines IL-6, IL-12, IL-17, IL-23, IFN-γ, LPS, TNF-α, TNFR1 and TNFR2 and increase anti-inflammatory cytokines IL-2 and TGF-β in rats with ulcerative colitis and reduce the intestinal inflammation.
Research conclusions
Our findings suggest that moxibustion exerts its therapeutic effect by modulating the microbiome and intestinal mucosal immunity.
Research perspectives
The present study may provide a certain experimental basis and scientific basis for the clinical curative effect of the treatment of UC.
